P

Assignee

ARCTURUS THERAPEUTICS INC

US61 patents

Top patents by PatentIndex Score

US9593077B2Mar 14, 2017

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC88 citations99
US9567296B2Feb 14, 2017

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC77 citations99
US9670152B2Jun 6, 2017

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC52 citations98
US10526284B2Jan 7, 2020

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC16 citations94
US10487105B2Nov 26, 2019

Trinucleotide MRNA cap analogs

ARCTURUS THERAPEUTICS INC19 citations94
US9896413B2Feb 20, 2018

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC19 citations94
US9365610B2Jun 14, 2016

Asymmetric ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC30 citations94
US9951002B2Apr 24, 2018

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC12 citations93
US9850202B2Dec 26, 2017

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC15 citations93
US10383952B2Aug 20, 2019

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC13 citations92
US9580711B2Feb 28, 2017

Lipid particles with asymmetric cationic lipids for RNA delivery

ARCTURUS THERAPEUTICS INC20 citations92
US9051570B2Jun 9, 2015

UNA oligomers for therapeutics

ARCTURUS THERAPEUTICS INC17 citations92
USRE49233EOct 4, 2022

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC2 citations84
US10980895B2Apr 20, 2021

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC8 citations84
US10961188B2Mar 30, 2021

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC7 citations84
US10781169B2Sep 22, 2020

Method of synthesis of an ionizable cationic lipid

ARCTURUS THERAPEUTICS INC6 citations84
US10457945B2Oct 29, 2019

UNA oligomers for therapeutics with prolonged stability

ARCTURUS THERAPEUTICS INC3 citations84
US10399937B2Sep 3, 2019

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC2 citations84
US10233148B2Mar 19, 2019

Aromatic ionizable cationic lipid

ARCTURUS THERAPEUTICS INC6 citations84
US10227302B2Mar 12, 2019

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC12 citations84
US9944929B2Apr 17, 2018

UNA single stranded oligomers for therapeutics

ARCTURUS THERAPEUTICS INC4 citations84
US9856475B2Jan 2, 2018

Formulations for treating amyloidosis

ARCTURUS THERAPEUTICS INC5 citations84
US9303260B2Apr 5, 2016

UNA duplex oligomers for therapeutics

ARCTURUS THERAPEUTICS INC6 citations84
US9297009B2Mar 29, 2016

UNA oligomers targeting micro-RNA for therapeutics

ARCTURUS THERAPEUTICS INC8 citations84
US11744887B2Sep 5, 2023

Coronavirus vaccine compositions and methods

ARCTURUS THERAPEUTICS INC4 citations82
US10369232B2Aug 6, 2019

Allele selective gene editing and uses thereof

ARCTURUS THERAPEUTICS INC14 citations81
US11015204B2May 25, 2021

Synthesis and structure of high potency RNA therapeutics

ARCTURUS THERAPEUTICS INC6 citations80
US10815463B2Oct 27, 2020

Messenger UNA molecules and uses thereof

ARCTURUS THERAPEUTICS INC6 citations73
US10556861B2Feb 11, 2020

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC1 citations73
US10421964B2Sep 24, 2019

UNA oligomers and compositions for treating amyloidosis

ARCTURUS THERAPEUTICS INC2 citations73
US9982259B2May 29, 2018

Transthyretin allele selective UNA oligomers for gene silencing

ARCTURUS THERAPEUTICS INC5 citations73
US9834510B2Dec 5, 2017

Aromatic ionizable cationic lipid

ARCTURUS THERAPEUTICS INC4 citations73
US11685906B2Jun 27, 2023

Compositions and methods for treating ornithine transcarbamylase deficiency

ARCTURUS THERAPEUTICS INC4 citations72
US12220455B2Feb 11, 2025

Coronavirus vaccine compositions and methods

ARCTURUS THERAPEUTICS INC1 citations71
US11759515B2Sep 19, 2023

Compositions and methods for inducing immune responses

ARCTURUS THERAPEUTICS INC1 citations70
US11938227B2Mar 26, 2024

Lipid nanoparticles encapsulation of large RNA

ARCTURUS THERAPEUTICS INC2 citations65
USRE50681EDec 2, 2025

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC0 citations63
US12286395B2Apr 29, 2025

Method of synthesis of an ionizable cationic lipid

ARCTURUS THERAPEUTICS INC0 citations63
US12527881B2Jan 20, 2026

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC0 citations62
US12220485B2Feb 11, 2025

Method of making lipid-encapsulated RNA nanoparticles

ARCTURUS THERAPEUTICS INC0 citations62
US11737979B2Aug 29, 2023

Method of making lipid-encapsulated RNA nanoparticles

ARCTURUS THERAPEUTICS INC1 citations62
US12290567B2May 6, 2025

Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates

ARCTURUS THERAPEUTICS INC1 citations61
US12398379B2Aug 26, 2025

Compositions and methods for treating ornithine transcarbamylase deficiency

ARCTURUS THERAPEUTICS INC0 citations60
US12390524B2Aug 19, 2025

Compositions and methods for inducing immune responses

ARCTURUS THERAPEUTICS INC0 citations59
US11939363B2Mar 26, 2024

Translatable molecules and synthesis thereof

ARCTURUS THERAPEUTICS INC0 citations59
US11407800B2Aug 9, 2022

Translatable molecules and synthesis thereof

ARCTURUS THERAPEUTICS INC1 citations59
US12509698B2Dec 30, 2025

Synthesis and structure of high potency RNA therapeutics

ARCTURUS THERAPEUTICS INC0 citations58
US12178921B2Dec 31, 2024

Method of lyophilizing lipid nanoparticles

ARCTURUS THERAPEUTICS INC0 citations58
US12070509B2Aug 27, 2024

Nucleic acids and methods of treatment for cystic fibrosis

ARCTURUS THERAPEUTICS INC1 citations57
US12351834B2Jul 8, 2025

Compositions and methods for the treatment of ornithine transcarbamylase deficiency

ARCTURUS THERAPEUTICS INC0 citations56

Showing the top 50 of 61 patents by PatentIndex Score.